A new study conducted by the National Eye Institute (NEI) has found that when people with type 2 diabetes intensively controlled their blood sugar levels, their diabetic retinopathy risk was cut in half.
The study included patients who participated in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study, who were then followed-up during the ACCORD Follow-on Eye Study (ACCORDION) four years after stopping intensive therapy. ACCORDION found diabetic retinopathy had advanced in only 5.8 percent of the participants in the intensive therapy group since enrollment in ACCORD, compared to 12.7 percent in the standard therapy group.
Click here to read the full press release.
Source: National Eye Institute